Loading...

LXEO LEXEO THERAPEUTICS INC Management Changes 8-K Filing

LX T

LX

LEXEO THERAPEUTICS INC

(LXEO)

2026 8-K

Financial Results Update

Director Appointment

Business Highlights

Management Change

Management Changes

Positive Clinical Data

Financial Results Announced

Funding Announcements

Regulatory Update

CFO Transition Announcement

Equity Offerings

Financial Statements

Clinical Data Announcement

Financial Results

Corporate Presentation

CFO Appointment

Management Change

Clinical Data Release

Corporate Update

External Links:

Lexeo Therapeutics, Inc. appointed Dr. Laura Sepp-Lorenzino to its board on April 28, 2026, with an annual compensation of $40,000 and an initial stock option award of 50,000 shares.

AI Assistant

LEXEO THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.